thus , pyrithiamine treatment leads to reductions of cerebral alpha kgdh and ( 1 ) decreased glucose ( pyruvate ) oxidation resulting in accumulation of alanine and ( 2 ) decreased brain content of glutamate and aspartate .
C0006104
brain
C0423896
content